Follow

Submissions from 2020

Link

Methotrexate in Psoriasis and Psoriatic Arthritis., Laura C Coates, Joseph F Merola, Suzanne M Grieb, Philip Mease, and Kristina Callis Duffin

Link

Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study., Laura C Coates, Peter Nash, Tore K Kvien, Laure Gossec, Philip Mease, Lawrence Rasouliyan, Luminita Pricop, Steffen M Jugl, Kunal K Gandhi, Corine Gaillez, and Josef S Smolen

Link

GRAPPA 2019 Project Report., Niti Goel, Laura C Coates, Gabriele De Marco, Lihi Eder, Oliver FitzGerald, Philip S Helliwell, Ying Ying Leung, Walter P Maksymowych, Philip Mease, Mikkel Østergaard, Denis O'Sullivan, Denis Poddubnyy, Christopher T Ritchlin, and Dafna D Gladman

Link

Secukinumab Efficacy in Psoriatic Arthritis: Machine Learning and Meta-analysis of Four Phase 3 Trials., Alice B Gottlieb, Philip Mease, Bruce Kirkham, Peter Nash, Alejandro C Balsa, Bernard Combe, Jürgen Rech, Xuan Zhu, David James, Ruvie Martin, Gregory Ligozio, Ken Abrams, and Luminita Pricop

Link

Appraisal of candidate instruments for assessment of the physical function domain in patients with psoriatic arthritis., Ying Ying Leung, Ana-Maria Orbai, Alexis Ogdie, Pil Hojgaard, Richard Holland, Niti Goel, Jeffrey Chau, Laura C Coates, Vibeke Strand, Dafna D Gladman, Philip Mease, Robin Christensen, and William Tillett

Link

The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates., Ying Ying Leung, William Tillett, Ana-Maria Orbai, Alexis Ogdie, Lihi Eder, Laura C Coates, Richard Holland, Anna Antony, Niti Goel, Philip Mease, Vibeke Strand, Oliver FitzGerald, Maarten de Wit, Christine A Lindsay, Kristina Callis Duffin, and Dafna D Gladman

Link

Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis., Sara C Martinez, Mohamed Mohamed, Jessica Potts, Abhishek Abhishek, Edward Roddy, Michael Savage, Aditya Bharadwaj, Chun Shing Kwok, Rodrigo Bagur, and Mamas A Mamas

Link

Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis., Sara C Martinez, Mohamed Mohamed, Jessica Potts, Abhishek Abhishek, Edward Roddy, Michael Savage, Aditya Bharadwaj, Chun Shing Kwok, Rodrigo Bagur, and Mamas A Mamas

Link

Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks., Helena Marzo-Ortega, Philip Mease, Proton Rahman, Victoria Navarro-Compán, Vibeke Strand, Maxime Dougados, Bernard Combe, James Cheng-Chung Wei, Xenofon Baraliakos, Theresa Hunter, David Sandoval, Xiaoqi Li, Baojin Zhu, Louis Bessette, and Atul Deodhar

Link

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial., Iain B McInnes, Frank Behrens, Philip Mease, Arthur Kavanaugh, Christopher Ritchlin, Peter Nash, Jordi Gratacós Masmitja, Philippe Goupille, Tatiana Korotaeva, Alice B Gottlieb, Ruvie Martin, Kevin Ding, Pascale Pellet, Shephard Mpofu, and Luminita Pricop

PDF

Enthesitis in psoriatic arthritis (Part 3): clinical assessment and management., Philip Mease

PDF

Preface to the psoriatic arthritis supplement., Philip Mease

Link

Reply to Letter to the Editor on Mease et al., Philip Mease, David H Collier, Gregory Kricorian, and James B Chung

Link

Evaluation of changes in skin and joint outcomes and associated treatment changes in PsA: Experience from the Corrona PsA/SpA Registry., Philip Mease, Carol J Etzel, William Huster, April Armstrong, Talia Muram, Jeffrey Lisse, Sabrina Rebello, Rhiannon Dodge, Mwangi J Murage, Jeffrey D Greenberg, and William Malatestinic

Link

Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study., Philip Mease, Dafna D Gladman, Atul Deodhar, Dennis G McGonagle, Peter Nash, Wolf-Henning Boehncke, Alice Gottlieb, Xie L Xu, Stephen Xu, Elizabeth C Hsia, Chetan S Karyekar, and Philip S Helliwell

Link

Treatment to Target in Psoriatic Arthritis with Apremilast: Probability of Achieving Targets and Comprehensive Control of Disease Manifestations., Philip Mease, Dafna D Gladman, Alexis Ogdie, Laura C Coates, Frank Behrens, Arthur Kavanaugh, Iain Mcinnes, Rubén Queiro, Benoit Guerette, Michele Brunori, Lichen Teng, and Josef S Smolen

PDF

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial., Philip Mease, M Elaine Husni, Shelly Kafka, Soumya D Chakravarty, Diane D Harrison, Kim Hung Lo, Stephen Xu, Elizabeth C Hsia, and Arthur Kavanaugh

PDF

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 Study., Philip Mease, Arthur Kavanaugh, Andreas Reimold, Hasan Tahir, Juergen Rech, Stephen Hall, Piet Geusens, Pascale Pellet, Eumorphia Maria Delicha, Luminita Pricop, and Shephard Mpofu

Link

Disease Characteristics, Quality of Life, and Work Productivity by Enthesitis Site: Real- World Data From the US Corrona Psoriatic Arthritis/Spondyloarthritis Registry., Philip Mease, Mei Liu, Sabrina Rebello, Winnie Hua, Robert R McLean, Peter Hur, and Alexis Ogdie

PDF

Characterization of Patients With Axial Spondyloarthritis by Enthesitis Presence: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry., Philip Mease, Mei Liu, Sabrina Rebello, Winnie Hua, Robert R McLean, Esther Yi, Yujin Park, and Alexis Ogdie

Link

Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial., Philip Mease, Proton Rahman, Alice B Gottlieb, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang, Désirée van der Heijde, and Iain B McInnes

PDF

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial., Philip Mease, Josef S Smolen, Frank Behrens, Peter Nash, Soyi Liu Leage, Lingnan Li, Hasan Tahir, Melinda Gooderham, Eswar Krishnan, Hong Liu-Seifert, Paul Emery, Sreekumar G Pillai, and Philip S Helliwell

Link

Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study., Peter Nash, Laura C Coates, Alan J Kivitz, Philip Mease, Dafna D Gladman, José A Covarrubias-Cobos, Oliver FitzGerald, Dona Fleishaker, Cunshan Wang, Joseph Wu, Ming-Ann Hsu, Sujatha Menon, Lara Fallon, Ana Belén Romero, and Keith S Kanik

Link

Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations., Shannon M Smith, Robert H Dworkin, Dennis C Turk, Michael McDermott, Christopher Eccleston, John T Farrar, Michael C Rowbotham, Zubin Bhangwagar, Laurie B Burke, Penney Cowan, Susan S Ellenberg, Scott R Evans, Roy L Freeman, Louis P Garrison, Smriti Iyengar, Alejandro Jadad, Mark P Jensen, Roderick Junor, Cornelia Kamp, Nathaniel P Katz, J Patrick Kesslak, Ernest A Kopecky, Dmitri Lissin, John D Markman, Philip Mease, Alec B O'Connor, Kushang V Patel, Srinivasa N Raja, Cristina Sampaio, David Schoenfeld, Jasvinder Singh, Ilona Steigerwald, Vibeke Strand, Leslie A Tive, Jeffrey Tobias, Ajay D Wasan, and Hilary D Wilson

Link

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52., Josef S Smolen, Philip Mease, Hasan Tahir, Hendrik Schulze-Koops, Inmaculada de la Torre, Lingnan Li, Maja Hojnik, Christophe Sapin, Masato Okada, Roberto Caporali, Jordi Gratacós, Philippe Goupille, Soyi Liu Leage, Sreekumar Pillai, and Peter Nash

Link

An interferon-gamma release assay as a novel biomarker in systemic lupus erythematosus., Jenna L Thomason, Uchechukwu M Obih, David M Koelle, Christian Lood, and And Grant Hughes

Link

Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps., William Tillett, Neil McHugh, Ana-Maria Orbai, Alexis Ogdie, Ying Ying Leung, Laura C Coates, Philip Mease, Dafna D Gladman, Mel Brooke, Jon Packham, Denis O'Sullivan, Oliver FitzGerald, and Philip S Helliwell

PDF

Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research., Désirée van der Heijde, Dafna D Gladman, Arthur Kavanaugh, and Philip Mease

Link

Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting., Robin Waxman, Carmel Stober, Deepak R Jadon, Ana-Maria Orbai, Vinod Chandran, Alexis Ogdie, Stephen R Pennington, Maarten de Wit, Denis O'Sullivan, Philip Mease, April W Armstrong, Kristina Callis Duffin, Philip S Helliwell, Leonieke J J van Mens, Christopher T Ritchlin, and Oliver FitzGerald

PDF

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019., Kevin L Winthrop, Michael E Weinblatt, Joan Bathon, Gerd R Burmester, Philip Mease, Leslie Crofford, Vivian Bykerk, Maxime Dougados, James Todd Rosenbaum, Xavier Mariette, Joachim Sieper, Fritz Melchers, Bruce N Cronstein, Ferry C Breedveld, Joachim Kalden, Josef S Smolen, and Daniel Furst

Submissions from 2019

PDF

Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population., Diana Brixner, Manish Mittal, David T Rubin, Philip Mease, Harry H Liu, Matthew Davis, Arijit Ganguli, and A Mark Fendrick

Link

Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018., Alessandro Chiarotto, Ulrike Kaiser, Ernest Choy, Robin Christensen, Philip G Conaghan, Mary Cowern, Michael Gill, Maarten de Wit, Elizabeth Gargon, Ben Horgan, Jamie J Kirkham, Lee S Simon, Jasvinder A Singh, Peter Tugwell, Dennis C Turk, and Philip Mease

PDF

Measurement properties of the minimal disease activity criteria for psoriatic arthritis., Laura C Coates, Vibeke Strand, Hilary Wilson, Dennis Revicki, Brad Stolshek, Ahmed Samad, James B Chung, Dafna Gladman, and Philip Mease

PDF

Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies., Laura C Coates, Johan K Wallman, Dennis McGonagle, Georg A Schett, Iain B McInnes, Philip Mease, Lawrence Rasouliyan, Erhard Quebe-Fehling, Darren L Asquith, Andreas E R Fasth, Luminita Pricop, and Corine Gaillez

PDF

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data., A Deodhar, Philip Mease, I B McInnes, X Baraliakos, K Reich, A Blauvelt, C Leonardi, B Porter, A Das Gupta, A Widmer, L Pricop, and T Fox

PDF

Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap., Atul Deodhar, Lianne S Gensler, Marina Magrey, Jessica A Walsh, Adam Winseck, Daniel Grant, and Philip Mease

Link

Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity: OMERACT 2018 Psoriatic Arthritis workshop report., Alí Duarte-García, Ying Ying Leung, Laura C Coates, Dorcas Beaton, Robin Christensen, Ethan T Craig, Maarten de Wit, Lihi Eder, Lara Fallon, Oliver FitzGerald, Dafna D Gladman, Niti Goel, Richard Holland, Chris Lindsay, Lara Maxwell, Philip Mease, Ana Maria Orbai, Bev Shea, Vibeke Strand, Douglas J Veale, William Tillett, and Alexis Ogdie

Link

GRAPPA 2018 Project Report., Niti Goel, Oliver FitzGerald, Dafna D Gladman, Philip S Helliwell, Arthur Kavanaugh, Walter P Maksymowych, Philip Mease, Christopher T Ritchlin, and Laura C Coates

Link

Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis: A Prospective Cohort Study., Pil Højgaard, Karen Ellegaard, Sabrina Mai Nielsen, Robin Christensen, Jørgen Guldberg-Møller, Christine Ballegaard, Lene Dreyer, Philip Mease, Maarten de Wit, Lone Skov, Bente Glintborg, Henning Bliddal, Else Marie Bartels, Kirstine Amris, and Lars Erik Kristensen

Link

Prevalence of Crystals in Knee Osteoarthritis: Experience From Patients Undergoing Arthroscopic Procedures., Robert Ike, Amrutha Baskaran, Jeannie Chao, Andrew L Concoff, Christopher W Wu, Bob Sun, Paul H Brion, Erin L Arnold, David J Klashman, John FitzGerald, and Kenneth C Kalunian

Link

Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting., Deepak R Jadon, Vinod Chandran, Alexis Ogdie, Stephen R Pennington, Carmel Stober, Dafna D Gladman, Maarten de Wit, Denis O'Sullivan, Philip Mease, April W Armstrong, Kristina Callis Duffin, Conor Magee, Philip Helliwell, Christopher T Ritchlin, and Oliver FitzGerald

PDF

Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis., Arthur Kavanaugh, Dafna D Gladman, Christopher J Edwards, Georg Schett, Benoit Guerette, Nikolay Delev, Lichen Teng, Maria Paris, and Philip Mease

Link

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set., Ying Ying Leung, Ana-Maria Orbai, Alexis Ogdie, Laura C Coates, Maarten de Wit, Kristina Callis Duffin, Lihi Eder, Dafna D Gladman, Niti Goel, Philip Mease, Vibeke Strand, Oliver FitzGerald, and William Tillett

PDF

Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a, Iain B McInnes, Gianfranco Ferraccioli, Maria-Antonietta D'Agostino, Manuela Le Bars, Subhashis Banerjee, Harris A Ahmad, Yedid Elbez, and Philip Mease

Link

Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis., Philip Mease

Link

Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results., Philip Mease

Link

Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting., Philip Mease, Neil A Accortt, Sabrina Rebello, Carol J Etzel, Ryan W Harrison, Girish A Aras, Mahdi M F Gharaibeh, Jeffrey D Greenberg, and David H Collier

PDF

Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry., Philip Mease, Carol J Etzel, William J Huster, Talia M Muram, April W Armstrong, Jeffrey R Lisse, Sabrina Rebello, Rhiannon Dodge, Mwangi James Murage, Jeffrey D Greenberg, and William N Malatestinic

Link

Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase 3 Trial., Philip Mease, Dafna D Gladman, David H Collier, Christopher T Ritchlin, Philip S Helliwell, Lyrica Liu, Gregory Kricorian, and James B Chung

PDF

Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study from the US-based Corrona registry., Philip Mease, Chitra Karki, Mei Liu, YouFu Li, Bernice Gershenson, Hua Feng, Peter Hur, and Jeffrey D Greenberg

Link

Axial Spondyloarthritis, Philip Mease and Muhammad Asim Khan

Link

Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study., Philip Mease, Clive Liu, Evan Siegel, Heather Richmond, Meijing Wu, Liang Chen, Kevin Douglas, and Benjamin Lockshin

Link

Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries., Philip Mease, Mei Liu, Sabrina Rebello, Hyungjoo Kang, Esther Yi, Yujin Park, and Jeffrey D Greenberg

Link

Utilization of the validated Psoriasis Epidemiology Screening Tool (PEST) to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry., Philip Mease, J B Palmer, P Hur, B E Strober, M Lebwohl, C Karki, G W Reed, C J Etzel, J D Greenberg, and P S Helliwell

Link

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial., Philip Mease, Josef S Smolen, Frank Behrens, Peter Nash, Soyi Liu Leage, Lingnan Li, Hasan Tahir, Melinda Gooderham, Eswar Krishnan, Hong Liu-Seifert, Paul Emery, Sreekumar G Pillai, and Philip S Helliwell

Link

Biologic Treatment of Axial Spondyloarthritis, Philip Mease and F. Van den Bosch

Link

Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis., Philip Mease, Jessica A Walsh, Xenofon Baraliakos, Robert Inman, Kurt de Vlam, James Cheng-Chung Wei, Theresa Hunter, Gaia Gallo, David Sandoval, Fangyi Zhao, Yan Dong, Rebecca Bolce, and Helena Marzo-Ortega

Link

The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis., Philippe Mertz, Alexandre Belot, Ricard Cervera, Tyng Yu Chuah, Lorenzo Dagna, Laura Damian, Debashish Danda, David D'cruz, Gerard Espinosa, Camille Frances, David Jayne, Kong Kok Ooi, Eugene J Kucharz, Robert Lebovics, Isabelle Marie, Guillaume Moulis, Stanford Peng, Aman Sharma, Noboru Suzuki, Toshio Tanaka, Ronald Van Vollenhoven, Jean Sibilia, Jacques Eric Gottenberg, François Chasset, and Laurent Arnaud

Link

Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor., Alexis Ogdie, J Lynn Palmer, Jeffrey Greenberg, Jeffrey R Curtis, Leslie R Harrold, Daniel H Solomon, Arthur Kavanaugh, Joel M Kremer, and Philip Mease

Link

Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients., Ana-Maria Orbai, Iain B McInnes, Laura C Coates, M Elaine Husni, Dafna D Gladman, Laure Gossec, Luminita Pricop, Olivier Chambenoit, Xiangyi Meng, and Philip Mease

Link

Measuring Psoriatic Arthritis Symptoms, A Core Domain in Psoriasis Clinical Trials., Lourdes Maria Perez-Chada, Alice Bendix Gottlieb, Jeffrey Cohen, Philip Mease, Kristina Callis Duffin, Amit Garg, John Latella, April Wang Armstrong, Alexis Ogdie, and Joseph Frank Merola

Link

Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial., Thomas J Schnitzer, Richard Easton, Shirley Pang, Dennis J Levinson, Glenn Pixton, Lars Viktrup, Isabelle Davignon, Mark T Brown, Christine R West, and Kenneth M Verburg

Link

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis., Jasvinder A Singh, Gordon Guyatt, Alexis Ogdie, Dafna D Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M Elaine Husni, Sarah Kenny, Jennifer Kwan-Morley, Janice Lin, Paula Marchetta, Philip Mease, Joseph F Merola, Julie Miner, Christopher T Ritchlin, Bernadette Siaton, Benjamin J Smith, Abby S Van Voorhees, Anna Helena Jonsson, Amit Aakash Shah, Nancy Sullivan, Marat Turgunbaev, Laura C Coates, Alice Gottlieb, Marina Magrey, W Benjamin Nowell, Ana-Maria Orbai, Soumya M Reddy, Jose U Scher, Evan Siegel, Michael Siegel, Jessica A Walsh, Amy S Turner, and James Reston

Link

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis., Jasvinder A Singh, Gordon Guyatt, Alexis Ogdie, Dafna D Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M Elaine Husni, Sarah Kenny, Jennifer Kwan-Morley, Janice Lin, Paula Marchetta, Philip Mease, Joseph F Merola, Julie Miner, Christopher T Ritchlin, Bernadette Siaton, Benjamin J Smith, Abby S Van Voorhees, Anna Helena Jonsson, Amit Aakash Shah, Nancy Sullivan, Marat Turgunbaev, Laura C Coates, Alice Gottlieb, Marina Magrey, W Benjamin Nowell, Ana-Maria Orbai, Soumya M Reddy, Jose U Scher, Evan Siegel, Michael Siegel, Jessica A Walsh, Amy S Turner, and James Reston

PDF

Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study., Josef S Smolen, Dafna Gladman, H Patrick McNeil, Philip J Mease, Joachim Sieper, Maja Hojnik, Pascal Nurwakagari, and John Weinman

PDF

Consumer Prices for Surgical Management of Ankle Arthritis: Limited Availability and Wide Variability., Niall A Smyth, Brody J Dawkins, Joshua P Goldstein, Jonathan R Kaplan, Lew C Schon, and Amiethab A Aiyer

PDF

Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond., Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Philip Mease, Dafna D Gladman, Linda Chen, Elizabeth Kudlacz, Joseph Wu, Joseph C Cappelleri, Thijs Hendrikx, and Ming-Ann Hsu

PDF

Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden-a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs., Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Philip Mease, Dafna D Gladman, Daniela Graham, Cunshan Wang, Joseph C Cappelleri, Thijs Hendrikx, and Ming-Ann Hsu

Link

Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis., Vibeke Strand, Iain McInnes, Philip Mease, Peter Nash, Howard Thom, Chrysostomos Kalyvas, Matthias Hunger, Kunal Gandhi, Luminita Pricop, Steffen Jugl, and Ernest Choy

Link

Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5., Désirée van der Heijde, Philip Mease, Robert B M Landewé, Proton Rahman, Hasan Tahir, Atul Singhal, Elke Boettcher, Sandra Navarra, Xuan Zhu, Gregory Ligozio, Aimee Readie, Shephard Mpofu, and Luminita Pricop

Link

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019., Kevin L Winthrop, Michael E Weinblatt, Joan Bathon, Gerd R Burmester, Philip Mease, Leslie Crofford, Vivian Bykerk, Maxime Dougados, James Todd Rosenbaum, Xavier Mariette, Joachim Sieper, Fritz Melchers, Bruce N Cronstein, Ferry C Breedveld, Joachim Kalden, Josef S Smolen, and Daniel Furst

Link

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018., Kevin L Winthrop, Michael E Weinblatt, Mary K Crow, Gerd R Burmester, Philip Mease, Alexander K So, Vivian Bykerk, Ronald F Van Vollenhoven, Maxime Dougados, Jonathan Kay, Xavier Mariette, Joachim Sieper, Fritz Melchers, Bruce N Cronstein, Ethan Shevach, Ferdinand C Breedfeld, Joachim Kalden, Josef S Smolen, and Daniel E Furst

Link

Revised chronic widespread pain criteria: development from and integration with fibromyalgia criteria., Frederick Wolfe, Stephen H Butler, MaryAnn Fitzcharles, Winfried Häuser, Robert L Katz, Philip Mease, Johannes J Rasker, Anthony S Russell, I Jon Russell, and Brian Walitt

Submissions from 2018

Link

Anti-Inflammatory Effects of Intra-Articular Hyaluronic Acid: A Systematic Review., Roy Altman, Asheesh Bedi, Ajay Manjoo, Faizan Niazi, Peter Shaw, and Philip Mease

Link

Trial Characteristics as Contextual Factors When Evaluating Targeted Therapies in Patients With Psoriatic Disease: A Meta-Epidemiologic Study., Christine Ballegaard, Tanja S Jørgensen, Marie Skougaard, Vibeke Strand, Philip Mease, Lars E Kristensen, Lene Dreyer, Alice Gottlieb, Maarten de Wit, Robin Christensen, and Simon Tarp

Link

Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study., Matthew A Brown, Paul A Bird, Philip C Robinson, Philip Mease, Filip van den Bosch, Christine Surian, Heather Jones, Annette Szumski, Lisa Marshall, Zirke Wiid, and Maxime Dougados

Link

GRAPPA 2017 Project Report., Kristina Callis Duffin, Oliver FitzGerald, Artie Kavanaugh, Philip Mease, Joseph F Merola, Alexis Ogdie, Denis O'Sullivan, Soumya M Reddy, Christopher T Ritchlin, and Laura C Coates

Link

Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study., Alberto Cauli, Dafna D Gladman, Alessandro Mathieu, Ignazio Olivieri, Giovanni Porru, Paul P Tak, Claudia Sardu, Raffaele Scarpa, Antonio Marchesoni, William J Taylor, Carlo Salvarani, Joachim Kalden, Ennio Lubrano, Sueli Carneiro, Matteo Piga, Alberto Floris, Francesca Desiati, John A Flynn, Salvatore D'Angelo, Arno W R van Kuijk, Maria Grazia Catanoso, Francesco Caso, Paolo Contu, Ilona Ujfalussy, Philip S Helliwell, and Philip Mease

Link

Remission in psoriatic arthritis-where are we now?, Laura C Coates, Philip G Conaghan, Maria Antonietta D'Agostino, Maarten De Wit, Oliver FitzGerald, Tore K Kvien, Rik Lories, Philip Mease, Peter Nash, Georg Schett, Enrique R Soriano, and Paul Emery

Link

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis., Laura C Coates, Oliver FitzGerald, Joseph F Merola, Josef Smolen, Leonieke J J van Mens, Heidi Bertheussen, Wolf-Henning Boehncke, Kristina Callis Duffin, Willemina Campbell, Maarten de Wit, Dafna Gladman, Alice Gottlieb, Jana James, Arthur Kavanaugh, Lars Erik Kristensen, Tore K Kvien, Thomas Luger, Neil McHugh, Philip Mease, Peter Nash, Alexis Ogdie, Cheryl F Rosen, Vibeke Strand, William Tillett, Douglas J Veale, and Philip S Helliwell

Link

Minimal Disease Activity among Active Psoriatic Arthritis Patients Treated with Secukinumab: 2-year Results from the FUTURE 2 Study., Laura C Coates, Philip Mease, Laure Gossec, Bruce Kirkham, Bintu Sherif, Corine Gaillez, Shephard Mpofu, Steffen M Jugl, Chetan Karyekar, and Kunal K Gandhi

Link

Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain., Edward Covington, Charles Argoff, and Steven P Stanos

Link

Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis., Mark C Genovese, Michael E Weinblatt, Philip J Mease, Jacob A Aelion, Paul M Peloso, Kun Chen, Yihan Li, John Liu, Ahmed A Othman, Amit Khatri, Heikki T Mansikka, and Piotr Leszczynski

Link

The Benefits and Challenges of Setting Up a Longitudinal Psoriatic Arthritis Database., Dafna D Gladman, Laura C Coates, Deepak R Jadon, William Tillett, Philip Mease, and Marijn Vis

PDF

Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies., Dafna D Gladman, Arthur Kavanaugh, Juan J Gómez-Reino, Jürgen Wollenhaupt, Maurizio Cutolo, Georg Schett, Eric Lespessailles, Benoit Guerette, Nikolay Delev, Lichen Teng, Christopher J Edwards, Charles A Birbara, and Philip J Mease

Link

The Effect of Psoriatic Arthritis on Ixekizumab Clinical Outcomes in Moderate-to-Severe Psoriasis Patients: A Post Hoc Analysis., Alice B Gottlieb, Kim A Papp, Charles A Birbara, Catherine L Shuler, Russel Burge, Janelle Erickson, Lisa Kerr, and Philip J Mease

Link

Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1)., Alice B Gottlieb, Vibeke Strand, Mitsumasa Kishimoto, Philip Mease, Diamant Thaçi, Julie Birt, Chin H Lee, Catherine L Shuler, Chen-Yen Lin, and Dafna D Gladman

Link

Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: A prospective cohort study., Pil Højgaard, Karen Ellegaard, Sabrina Mai Nielsen, Robin Christensen, Jørgen Guldberg-Møller, Christine Ballegaard, Lene Dreyer, Philip Mease, Maarten de Wit, Lone Skov, Bente Glintborg, Henning Bliddal, Else Marie Bartels, Kirstine Amris, and Lars Erik Kristensen

Link

A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative., Pil Højgaard, Louise Klokker, Ana-Maria Orbai, Kim Holmsted, Else M Bartels, Ying Ying Leung, Niti Goel, Maarten de Wit, Dafna D Gladman, Philip Mease, Lene Dreyer, Lars E Kristensen, Oliver FitzGerald, William Tillett, Laure Gossec, Philip Helliwell, Vibeke Strand, Alexis Ogdie, Caroline B Terwee, and Robin Christensen

Link

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting., Richard Holland, William Tillett, Alexis Ogdie, Ying Y Leung, Dafna D Gladman, Kristina Callis Duffin, Laura C Coates, Philip Mease, Lihi Eder, Vibeke Strand, Musaab Elmamoun, Pil Højgaard, Jeffrey Chau, Maarten de Wit, Niti Goel, Chris A Lindsay, Oliver FitzGerald, Bev Shea, Dorcas Beaton, and Ana-Maria Orbai

Link

Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study., Robert Landewé, Joachim Sieper, Philip Mease, Robert D Inman, Robert G Lambert, Atul Deodhar, Helena Marzo-Ortega, Marina Magrey, Uta Kiltz, Xin Wang, Mei Li, Sheng Zhong, Nael M Mostafa, Apinya Lertratanakul, Aileen L Pangan, and Jaclyn K Anderson

PDF

Classification and Outcome Measures for Psoriatic Arthritis., Ying Ying Leung, Alexis Ogdie, Ana-Maria Orbai, William Tillett, Laura C Coates, Vibeke Strand, Philip Mease, and Dafna D Gladman

Link

Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study., Iain B McInnes, Philip Mease, Georg Schett, Bruce Kirkham, Vibeke Strand, Nicole Williams, Todd Fox, Luminita Pricop, Steffen M Jugl, and Kunal K Gandhi

Link

Current and Emerging Treatments for Psoriatic Arthritis, Philip Mease

PDF

Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison., Philip Mease, Ernest Choy, Peter Nash, Chrysostomos Kalyvas, Matthias Hunger, Luminita Pricop, Kunal K Gandhi, Steffen M Jugl, and Howard Thom

Link

Considerations for the definition of remission criteria in psoriatic arthritis., Philip Mease and Laura C Coates

Link

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial., Philip Mease, Laura C Coates, Philip S Helliwell, Mykola Stanislavchuk, Anna Rychlewska-Hanczewska, Anna Dudek, Walid Abi-Saab, Chantal Tasset, Luc Meuleners, Pille Harrison, Robin Besuyen, Annegret Van der Aa, Neelufar Mozaffarian, Joy M Greer, Rebecca Kunder, Filip Van den Bosch, and Dafna D Gladman

Link

Phase 2 Study of ABT-122, a TNF- and IL-17A-Targeted Dual Variable Domain Immunoglobulin, in Psoriatic Arthritis With Inadequate Methotrexate Response., Philip Mease, Mark C Genovese, Michael E Weinblatt, Paul M Peloso, Kun Chen, Ahmed A Othman, Yihan Li, Heikki T Mansikka, Amit Khatri, Neil Wishart, and John Liu

Link

Tofacitinib for Psoriatic Arthritis., Philip Mease and Dafna Gladman

Link

Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)., Philip Mease, Dafna D Gladman, Ahmed S Samad, Laura C Coates, Lyrica X H Liu, Girish A Aras, David H Collier, and James B Chung